We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Madrigal Pharmaceuticals Inc | NASDAQ:MDGL | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -1.38 | -0.71% | 193.00 | 453,346 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 191.18 | 220.00 | 195.58 | 189.00 | 192.49 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | -373.63M | -18.7778 | -10.29 | 3.85B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 00:39:17 | formt | 100 | 193.00 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 13/9/2023 | 14:56 | DJN | Madrigal Gets FDA Priority Review of Resmetirom in NASH With Liver Fibrosis |
Madrigal Pharmaceuticals (MDGL) Share Charts1 Year Madrigal Pharmaceuticals Chart |
|
1 Month Madrigal Pharmaceuticals Chart |
Intraday Madrigal Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
